Our client is a Swiss multinational pharmaceutical company based in Basel. It is one of the largest pharmaceutical companies with a worldwide reach and a team of more than 110,000 employees. The company is a member of the EFPIA, IFPMA, and the PhRMA. The client required a study on breast cancer patients who are eligible for the following therapies:
• Hormone therapy
• Chemotherapy
• Targeted therapy
The research was aimed at understanding the overall treatment options in the current market. Also, understand the needs and expectations of the patients and simultaneously develop a benchmark for the Breast Cancer therapeutic market. Within the span of 3 weeks, 325 oncologists had been interviewed face-to-face in the countries of the USA, Canada, and UAE to obtain the required data.
Audience: Oncologist
Country: UAE
Time Span: 3 weeks
Sample Size: 325
Method: Face-to-face quantitative interviews